Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
46 hedge funds and large institutions have $39.1M invested in Albireo Pharma Inc in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
601% more capital invested
Capital invested by funds: $5.58M → $39.1M (+$33.6M)
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
35% more funds holding
Funds holding: 34 → 46 (+12)
63% less call options, than puts
Call options by funds: $18K | Put options by funds: $48K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.77M |
| 2 |
AIC
AWM Investment Company
New York
|
+$6.07M |
| 3 |
BC
Broadfin Capital
New York
|
+$4.76M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.49M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMA
FNY Managed Accounts
New York
|
-$151K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$117K |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$36K |
| 4 |
CC
Cannell & Co
New York
|
-$16K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$14.4K |
ALBO Hedge Fund Activity: Q2 2015 in Review
46 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2015, worth a combined $39.1M — up 601% from $5.58M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ALBO positions and 3 closed out — a net gain of 12 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $6.77M. The largest seller was FNY Managed Accounts, cutting an estimated $151K.
- 46 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2015, up from 34 in Q1 2015.
- Funds reported $39.1M of Albireo Pharma Inc stock for Q2 2015, up 601% quarter-over-quarter.
- 15 funds opened new Albireo Pharma Inc positions in Q2 2015 and 3 closed out, a net change of +12 holders.
- The largest Albireo Pharma Inc buyer in Q2 2015 was Wellington Management Group, an estimated $6.77M added.
- The largest Albireo Pharma Inc seller in Q2 2015 was FNY Managed Accounts, an estimated $151K sold.
Based on aggregated 13F filings for Q2 2015.